Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Stramer

Showing results (231-240 of 258) with videos related to

Pageof 26
Sort By:
Blood|July 10, 2020
HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concernBrian Custer, Claire Quiner, Richard Haaland, et al.
Transfusion|December 23, 2022
Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donorsNancy L Van Buren, Srijana Rajbhandary, Vanessa Reynolds, et al.
Transfusion|June 27, 2002
Sensitivity of HCV RNA and HIV RNA blood screening assaysP Nico Lelie, Harry A J van Drimmelen, H Theo M Cuypers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021Maureen J Miller, Austin Himschoot, Natalie Fitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2025
Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic TestingRebekah A Sutter, Amanda E Calvert, Kacie Grimm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021Michael P Busch, Susan L Stramer, Mars Stone, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
A <i>Trypanosoma cruzi</i> Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin AmericaHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
The Journal of Clinical Investigation|July 14, 2022
Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasmaPaula Saá, Rebecca V Fink, Sonia Bakkour, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Transfusion|October 22, 2025
An international survey of blood operator human T-cell lymphotropic virus-1/2 testing practicesSteven J Drews, Klara Baroti-Toth, Anthea Cheng, et al.
Pageof 26

Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
Blood|July 10, 2020
HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concernBrian Custer, Claire Quiner, Richard Haaland, et al.
Transfusion|December 23, 2022
Demographics of first-time donors returning for donation during the pandemic: COVID-19 convalescent plasma versus standard blood product donorsNancy L Van Buren, Srijana Rajbhandary, Vanessa Reynolds, et al.
Transfusion|June 27, 2002
Sensitivity of HCV RNA and HIV RNA blood screening assaysP Nico Lelie, Harry A J van Drimmelen, H Theo M Cuypers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021Maureen J Miller, Austin Himschoot, Natalie Fitch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2025
Jamestown Canyon Virus Seroprevalence in Endemic Regions and Implications for Diagnostic TestingRebekah A Sutter, Amanda E Calvert, Kacie Grimm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021Michael P Busch, Susan L Stramer, Mars Stone, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
A <i>Trypanosoma cruzi</i> Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin AmericaHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
The Journal of Clinical Investigation|July 14, 2022
Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasmaPaula Saá, Rebecca V Fink, Sonia Bakkour, et al.
The Journal of Clinical Investigation|February 5, 2026
A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regionsHannah M Kortbawi, Ryan J Marczak, Jayant V Rajan, et al.
Transfusion|October 22, 2025
An international survey of blood operator human T-cell lymphotropic virus-1/2 testing practicesSteven J Drews, Klara Baroti-Toth, Anthea Cheng, et al.
Pageof 26